使用小梁微旁路植入物iStent inject®预防青光眼进展：一项成本效益分析

数据集获取（Figshare）

• 源站标题：Preventing glaucoma progression using the trabecular micro-bypass implant iStent inject®. A cost-effectiveness analysis
• DOI：10.6084/m9.figshare.19928719.v1
• 发布日期：2022-05-30
• 文件数：10 个
• 文件总体积：13.87 MB
• 源站页面：https://scielo.figshare.com/articles/dataset/Preventing_glaucoma_progression_using_the_trabecular_micro-bypass_implant_iStent_inject_A_cost-effectiveness_analysis/19928719

命令行下载

curl -L -o "01f289e8e013125c109fdc077ec47a4e8793fb64.tif" "https://ndownloader.figshare.com/files/35439568"
curl -L -o "b03d531f4c538a2895cbdf0a268b64d76eec05c0.png" "https://ndownloader.figshare.com/files/35439571"
curl -L -o "9c8d6d4d8515fb45b0a73fd02164a0fa209b4e80.jpg" "https://ndownloader.figshare.com/files/35439574"
curl -L -o "d932d2943b58a8b597b5e3a2e801743a81cb5fd0.tif" "https://ndownloader.figshare.com/files/35439577"
curl -L -o "0163275caacbfeafdd29556160d68d804bf622b3.png" "https://ndownloader.figshare.com/files/35439580"
curl -L -o "8a3ea2b0e7f5399ff07b0f5f063fb5e9fe21478c.jpg" "https://ndownloader.figshare.com/files/35439583"
curl -L -o "Table_1.xls" "https://ndownloader.figshare.com/files/35439586"
curl -L -o "Table_2.xls" "https://ndownloader.figshare.com/files/35439589"

文件清单

• 01f289e8e013125c109fdc077ec47a4e8793fb64.tif（4.58 MB）
• b03d531f4c538a2895cbdf0a268b64d76eec05c0.png（262.81 KB）
• 9c8d6d4d8515fb45b0a73fd02164a0fa209b4e80.jpg（4.32 KB）
• d932d2943b58a8b597b5e3a2e801743a81cb5fd0.tif（8.67 MB）
• 0163275caacbfeafdd29556160d68d804bf622b3.png（327.43 KB）
• 8a3ea2b0e7f5399ff07b0f5f063fb5e9fe21478c.jpg（2.94 KB）
• Table_1.xls（9.73 KB）
• Table_2.xls（5.63 KB）
• Table_3.xls（5.63 KB）
• Table_4.xls（5.63 KB）

文件总体积 13.87 MB（源站 API 实测）。

数据加载示例（图像类）

from PIL import Image
import glob, os

files = (glob.glob(os.path.join(path, "**", "*.png"), recursive=True)
       + glob.glob(os.path.join(path, "**", "*.jpg"), recursive=True)
       + glob.glob(os.path.join(path, "**", "*.tif"), recursive=True))
print("图像文件数:", len(files))
img = Image.open(files[0]); print("尺寸/模式:", img.size, img.mode)

# torchvision Dataset 方式:
# from torchvision import datasets
# ds = datasets.ImageFolder(path)  # 要求 子目录=类别

目录组织与标注格式以源站说明和下载后实际文件为准。

数据说明

ABSTRACT Objective To assess the economic impact of reducing glaucoma progression by using the trabecular micro-bypass implant, iStent inject®, in the Reference Centers for glaucoma treatment within the Brazilian Public Unified Health System (SUS). Methods In a cost-effectiveness analysis, a Markov model was developed, and the costs were obtained from the SUS perspective (medical direct costs). Effectiveness was measured in progression-free life-years. The time horizon was the mean life expectancy of the Brazilian population. The model parameters were obtained through a review and a critical analysis of the literature. The base case comprised a hypothetical cohort of patients with open-angle glaucoma, using anti-glaucoma eye drops and followed up at Reference Centers of SUS. We tested whether the incorporation of iStent inject® as an alternative second-line therapy would be cost-effective. The outcome measure was the incremental cost-effectiveness ratio (R$/progression-free life-years). We tested the robustness of the model by univariate and probabilistic sensitivity analyses. Results The use of iStent inject® led to decreased progression rate of glaucoma, evidenced by the amount of progression-free life-years obtained with each treatment strategy (7.82 progression-free life-years with iStent inject® versus 6.33 progression-free life-years with medical treatment), thereby improving glaucoma control. There was also a reduction in future costs associated with eye drops, filtering surgeries, and treatment complications. Incremental cost-effectiveness ratio ranged from R$ 6,429.30 to R$ 7,550.97/progression-free life-years. The model proved to be robust in the sensitivity analyses. Conclusion This analysis showed that iStent inject®, when used after the failure of the first-line therapy, is able to reduce the rate of glaucoma progression at an acceptable cost.

许可

CC BY 4.0

引用

学术使用请引用 DOI 10.6084/m9.figshare.19928719.v1（source: https://scielo.figshare.com/articles/dataset/Preventing_glaucoma_progression_using_the_trabecular_micro-bypass_implant_iStent_inject_A_cost-effectiveness_analysis/19928719）。